Georgia Research Alliance Universities Sign Agreement to Share Core Facilities


ATLANTA – Research leaders from the eight universities in the Georgia Research Alliance (GRA) have signed a memorandum of understanding for the shared use of core research facilities at each of their institutions. The agreement means identified core facilities and equipment will be available to scientists at all eight institutions at the same rates and terms offered to internal facility users.

The GRA includes Mercer University, Augusta University, Clark Atlanta University, Emory University, Georgia Institute of Technology, Georgia State University, Morehouse School of Medicine and the University of Georgia.

“Being a part of the Georgia Research Alliance shared core facilities agreement provides Mercer with a tremendous expansion of state-of-the-art research equipment and technical expertise support for our faculty,” said Dr. Wayne Glasgow, senior vice provost for research and dean of graduate studies. “Having these resources available provides enhanced opportunities to more effectively address specific research questions and to develop productive research collaborations among GRA member institutions.”

The aim of the partnership agreement is to create a greater availability of research support services for faculty at all the Georgia research universities, to minimize duplication of resources, and to expand and maximize collaborative research opportunities.

“One of the key aims of the Georgia Research Alliance has always been to unite our research universities across the state in increasing biomedical innovation and economic development for the benefit of all Georgia citizens,” said C. Michael Cassidy, president of the GRA. “Sharing these core research facilities, which often include expensive equipment and specially trained personnel, is an ideal opportunity to enhance team science while increasing research efficiency and saving time and money.”

Core research facilities at the eight institutions include imaging; immunotherapy and immune monitoring; chemical and biomolecular analysis; genomics, proteomics, lipodomics, glycomics and metabolomics; nuclear magnetic resonance; mass spectrometry; flow cytometry; transgenic mouse and animal models; electron microscopy; cancer tissue and pathology; cellular imaging; molecular modeling and drug design; confocal microscopy; DNA sequencing; neuroscience (behavioral studies); brain imaging; high containment lab; isotope studies; nanotechnology; biomarkers; flow cytometry; biostatistics; high performance computing; and clinical trials.